Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Citi
Cerilliant
US Department of Justice
Colorcon
Chinese Patent Office
Baxter
Covington
McKesson
Merck

Generated: August 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018802

« Back to Dashboard
NDA 018802 describes BACTERIOSTATIC WATER FOR INJECTION IN PLASTIC CONTAINER, which is a drug marketed by Abraxis Pharm and Hospira and is included in three NDAs. It is available from four suppliers. Additional details are available on the BACTERIOSTATIC WATER FOR INJECTION IN PLASTIC CONTAINER profile page.

The generic ingredient in BACTERIOSTATIC WATER FOR INJECTION IN PLASTIC CONTAINER is sterile water for injection. There are one thousand and twenty-five drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the sterile water for injection profile page.

Summary for NDA: 018802

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 018802

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BACTERIOSTATIC WATER FOR INJECTION IN PLASTIC CONTAINER
sterile water for injection
LIQUID;N/A 018802 NDA Hospira, Inc. 0409-3977 0409-3977-03 25 VIAL, MULTI-DOSE in 1 TRAY (0409-3977-03) > 30 mL in 1 VIAL, MULTI-DOSE (0409-3977-01)
BACTERIOSTATIC WATER FOR INJECTION IN PLASTIC CONTAINER
sterile water for injection
LIQUID;N/A 018802 NDA General Injectables & Vaccine, Inc 52584-977 52584-977-03 1 VIAL, MULTI-DOSE in 1 BAG (52584-977-03) > 30 mL in 1 VIAL, MULTI-DOSE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:LIQUID;N/AStrength100%
Approval Date:Oct 27, 1982TE:APRLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
QuintilesIMS
Boehringer Ingelheim
Queensland Health
Mallinckrodt
Novartis
AstraZeneca
Deloitte
Teva
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot